Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer.

Seyfried TN, Mukherjee P, Iyikesici MS, Slocum A, Kalamian M, Spinosa JP, Chinopoulos C.

Front Nutr. 2020 Mar 11;7:21. doi: 10.3389/fnut.2020.00021. eCollection 2020. Review.

2.

Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.

Mukherjee P, Augur ZM, Li M, Hill C, Greenwood B, Domin MA, Kondakci G, Narain NR, Kiebish MA, Bronson RT, Arismendi-Morillo G, Chinopoulos C, Seyfried TN.

Commun Biol. 2019 May 29;2:200. doi: 10.1038/s42003-019-0455-x. eCollection 2019.

3.

Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Seyfried TN, Shelton L, Arismendi-Morillo G, Kalamian M, Elsakka A, Maroon J, Mukherjee P.

Neurochem Res. 2019 Oct;44(10):2392-2404. doi: 10.1007/s11064-019-02795-4. Epub 2019 Apr 25.

PMID:
31025151
4.

Personalized Nutrition in Disrupting Cancer - Proceedings From the 2017 American College of Nutrition Annual Meeting.

Wallace TC, Bultman S, D'Adamo C, Daniel CR, Debelius J, Ho E, Eliassen H, Lemanne D, Mukherjee P, Seyfried TN, Tian Q, Vahdat LT.

J Am Coll Nutr. 2019 Jan;38(1):1-14. doi: 10.1080/07315724.2018.1500499. Epub 2018 Dec 4. Erratum in: J Am Coll Nutr. 2019 Sep-Oct;38(7):659.

PMID:
30511901
5.

Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma.

Augur ZM, Doyle CM, Li M, Mukherjee P, Seyfried TN.

Front Nutr. 2018 Oct 5;5:91. doi: 10.3389/fnut.2018.00091. eCollection 2018.

6.

Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.

Elsakka AMA, Bary MA, Abdelzaher E, Elnaggar M, Kalamian M, Mukherjee P, Seyfried TN.

Front Nutr. 2018 Mar 29;5:20. doi: 10.3389/fnut.2018.00020. eCollection 2018.

7.

Perturbation of the yeast mitochondrial lipidome and associated membrane proteins following heterologous expression of Artemia-ANT.

Chen E, Kiebish MA, McDaniel J, Niedzwiecka K, Kucharczyk R, Ravasz D, Gao F, Narain NR, Sarangarajan R, Seyfried TN, Adam-Vizi V, Chinopoulos C.

Sci Rep. 2018 Apr 12;8(1):5915. doi: 10.1038/s41598-018-24305-2.

8.

Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells.

Flores RE, Brown AK, Taus L, Khoury J, Glover F, Kami K, Sarangarajan R, Walshe TE, Narain NR, Kiebish MA, Shelton LM, Chinopoulos C, Seyfried TN.

Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):975-983. doi: 10.1016/j.bbabio.2018.03.012. Epub 2018 Mar 23.

9.

Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis.

Chinopoulos C, Seyfried TN.

ASN Neuro. 2018 Jan-Dec;10:1759091418818261. doi: 10.1177/1759091418818261. Review.

10.

Environmental stimuli shape microglial plasticity in glioma.

Garofalo S, Porzia A, Mainiero F, Di Angelantonio S, Cortese B, Basilico B, Pagani F, Cignitti G, Chece G, Maggio R, Tremblay ME, Savage J, Bisht K, Esposito V, Bernardini G, Seyfried T, Mieczkowski J, Stepniak K, Kaminska B, Santoni A, Limatola C.

Elife. 2017 Dec 29;6. pii: e33415. doi: 10.7554/eLife.33415.

11.

Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer.

İyikesici MS, Slocum AK, Slocum A, Berkarda FB, Kalamian M, Seyfried TN.

Cureus. 2017 Jul 7;9(7):e1445. doi: 10.7759/cureus.1445.

12.

Quantification of metastatic load in a syngeneic murine model of metastasis.

Taus LJ, Flores RE, Seyfried TN.

Cancer Lett. 2017 Oct 1;405:56-62. doi: 10.1016/j.canlet.2017.07.011. Epub 2017 Jul 17.

PMID:
28729049
13.

Need for new review of article on ketogenic dietary regimes for cancer patients.

Klement RJ, Feinman RD, Gross EC, Champ CE, D'Agostino DP, Fine EJ, Kämmerer U, Poff A, Rho JM, Seyfried TN, Scheck AC.

Med Oncol. 2017 Jun;34(6):108. doi: 10.1007/s12032-017-0968-4. Epub 2017 Apr 27. No abstract available.

PMID:
28452037
14.

Ultrastructural characterization of the Mitochondria-associated membranes abnormalities in human astrocytomas: Functional and therapeutics implications.

Arismendi-Morillo G, Castellano-Ramírez A, Seyfried TN.

Ultrastruct Pathol. 2017 May-Jun;41(3):234-244. doi: 10.1080/01913123.2017.1300618. Epub 2017 Apr 4.

PMID:
28375672
16.

Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.

Seyfried TN, Yu G, Maroon JC, D'Agostino DP.

Nutr Metab (Lond). 2017 Feb 23;14:19. doi: 10.1186/s12986-017-0178-2. eCollection 2017.

17.

Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH.

Schwartz L, Seyfried T, Alfarouk KO, Da Veiga Moreira J, Fais S.

Semin Cancer Biol. 2017 Apr;43:134-138. doi: 10.1016/j.semcancer.2017.01.005. Epub 2017 Jan 22. Review.

PMID:
28122260
18.

The total and mitochondrial lipidome of Artemia franciscana encysted embryos.

Chen E, Kiebish MA, McDaniel J, Gao F, Narain NR, Sarangarajan R, Kacso G, Ravasz D, Seyfried TN, Adam-Vizi V, Chinopoulos C.

Biochim Biophys Acta. 2016 Nov;1861(11):1727-1735. doi: 10.1016/j.bbalip.2016.08.007. Epub 2016 Aug 16.

PMID:
27542539
19.

Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.

Schneider JS, Seyfried TN, Choi HS, Kidd SK.

PLoS One. 2015 Dec 2;10(12):e0143351. doi: 10.1371/journal.pone.0143351. eCollection 2015.

20.

Influence of Serum and Hypoxia on Incorporation of [(14)C]-D-Glucose or [(14)C]-L-Glutamine into Lipids and Lactate in Murine Glioblastoma Cells.

Ta NL, Seyfried TN.

Lipids. 2015 Dec;50(12):1167-84. doi: 10.1007/s11745-015-4075-z. Epub 2015 Nov 5.

PMID:
26537505

Supplemental Content

Loading ...
Support Center